94 related articles for article (PubMed ID: 16328523)
1. Commentary: Classification and grading of pituitary tumors. Observations of two working neuropathologists.
Perry A; Scheithauer BW
Acta Neuropathol; 2006 Jan; 111(1):68-70. PubMed ID: 16328523
[No Abstract] [Full Text] [Related]
2. Subtyping does matter in pituitary adenomas.
Kleinschmidt-DeMasters BK
Acta Neuropathol; 2006 Jan; 111(1):84-5. PubMed ID: 16328517
[No Abstract] [Full Text] [Related]
3. The 2004 World Health Organization classification of pituitary tumors: is it clinically helpful?
Grossman AB
Acta Neuropathol; 2006 Jan; 111(1):76-7. PubMed ID: 16328520
[No Abstract] [Full Text] [Related]
4. Innovations and controversies in the WHO classification of pituitary adenomas.
Kontogeorgos G
Acta Neuropathol; 2006 Jan; 111(1):73-5. PubMed ID: 16328521
[No Abstract] [Full Text] [Related]
5. Comment to the 2004 World Health Organization classification of pituitary tumors.
Saeger W
Acta Neuropathol; 2006 Jan; 111(1):64-5. PubMed ID: 16328525
[No Abstract] [Full Text] [Related]
6. The new WHO classification of human pituitary tumors: comments.
Figarella-Branger D; Trouillas J
Acta Neuropathol; 2006 Jan; 111(1):71-2. PubMed ID: 16328522
[No Abstract] [Full Text] [Related]
7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
8. Comments on the WHO histological classification of pituitary tumors.
Sano T
Acta Neuropathol; 2006 Jan; 111(1):82-3. PubMed ID: 16317556
[No Abstract] [Full Text] [Related]
9. The 2004 WHO classification of pituitary tumors: comments.
Kovacs K
Acta Neuropathol; 2006 Jan; 111(1):62-3. PubMed ID: 16315073
[No Abstract] [Full Text] [Related]
10. 2004 World Health Organization classification of pituitary tumors: what is new?
Melmed S
Acta Neuropathol; 2006 Jan; 111(1):78-9. PubMed ID: 16328519
[No Abstract] [Full Text] [Related]
11. The WHO typing of pituitary tumors: a commentary.
Farrell WE
Acta Neuropathol; 2006 Jan; 111(1):60-1. PubMed ID: 16328526
[No Abstract] [Full Text] [Related]
12. The WHO classification of pituitary tumours: a combined neurosurgical and neuropathological view.
Fahlbusch R; Buslei R
Acta Neuropathol; 2006 Jan; 111(1):86-7. PubMed ID: 16311771
[No Abstract] [Full Text] [Related]
13. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
14. Pituitary corticotroph adenoma containing many apoptotic cells: a histologic, immunohistochemical, ultrastructural and molecular study.
Messini I; Kontogeorgos G; Kovacs K; Horvath E; Smyth HS
Ultrastruct Pathol; 2002; 26(1):27-32. PubMed ID: 12028656
[TBL] [Abstract][Full Text] [Related]
15. The 2004 World Health Organization classification of pituitary tumors: what is new?
Al-Shraim M; Asa SL
Acta Neuropathol; 2006 Jan; 111(1):1-7. PubMed ID: 16328527
[TBL] [Abstract][Full Text] [Related]
16. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas.
Gejman R; Swearingen B; Hedley-Whyte ET
Hum Pathol; 2008 May; 39(5):758-66. PubMed ID: 18439942
[TBL] [Abstract][Full Text] [Related]
17. Atypical pituitary adenoma exhibiting densely secretory granules and basophilia without hormone production.
Mittelbronn M; Meyermann R; Honegger J
Neuro Endocrinol Lett; 2006; 27(1-2):93-6. PubMed ID: 16648809
[TBL] [Abstract][Full Text] [Related]
18. [Role of Ki-67, mutated gene-suppressor p53 and HER-2neu oncoprotein in the prognosis for the clinical course of bladder cancer].
Masliukova EA; Pozharisskiĭ KM; Karelin MI; Startsev VIu; Ten VP
Vopr Onkol; 2006; 52(6):643-8. PubMed ID: 17338241
[TBL] [Abstract][Full Text] [Related]
19. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors.
Wierinckx A; Auger C; Devauchelle P; Reynaud A; Chevallier P; Jan M; Perrin G; Fèvre-Montange M; Rey C; Figarella-Branger D; Raverot G; Belin MF; Lachuer J; Trouillas J
Endocr Relat Cancer; 2007 Sep; 14(3):887-900. PubMed ID: 17914117
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
